STOCK TITAN

Aterian (ATER) 8-K Filings

ATER NASDAQ

Every 8-K that Aterian, Inc. (ATER) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow ATER and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATER filings page.

Rhea-AI Summary

Aterian, Inc. entered into an unsecured promissory note with stockholder Chen Zhipeng, who agreed to make advances of up to $1,000,000. Advances accrue interest at 8.0% per annum; the note matures eight months after its date, subject to extension by mutual written agreement. Aterian may request draws before maturity, with each request subject to Chen’s written approval. Aterian’s direct financial obligation arises as advances are funded.

If Aterian proposes a cash private placement of equity or equity-linked securities, it must notify Chen at least 18 calendar days before the anticipated closing. Chen may elect cash repayment or apply all or part of the amount owed toward the placement at the same price and substantially the same terms as cash investors. If no such placement closes before maturity, Chen may elect conversion at a price equal to the Nasdaq Listing Rule 5635(d) “Minimum Price.” Issuances are subject to Nasdaq limits and applicable stockholder approval; any amount that cannot be applied or converted is payable in cash.

Rhea-AI Summary

Aterian, Inc. dismissed UHY LLP as its independent registered public accounting firm effective October 2, 2026, and appointed Haskell & White LLP effective immediately for the fiscal year ending December 31, 2026. UHY’s audit reports for the fiscal years ended December 31, 2025 and 2024 included a going-concern explanatory paragraph citing recurring operating losses, recurring negative operating cash flows, and possible difficulty funding day-to-day operations and complying with certain credit-facility covenants. Aterian reported no disagreements with UHY or reportable events during those fiscal years and the interim period through October 2, 2026.

Arturo Rodriguez’s employment ended September 30, 2026, after serving as Chief Executive Officer and then as a non-executive employee. Aterian engaged him as an independent contractor for limited advisory services at $250 per hour, subject to a limit of 12 hours per week and a $77,000 aggregate fee cap. Services are expected through November 20, 2026, then month-to-month until either party terminates the agreement, and no later than March 31, 2027.

Rhea-AI Summary

Aterian, Inc. says David E. Lazar, its Chief Executive Officer and Interim Chief Financial Officer, sold his interests and rights in 706,100 Series AA and 1,750,000 Series AAA preferred shares to purchasers for $12,000,000 on September 25, 2026. Immediately before the sale, the preferred shares were converted into 241,861,970 common shares. Lazar held approximately 3.1% of outstanding common stock afterward and may no longer be deemed to control Aterian. No purchaser held more than 9.99% of fully diluted common stock outstanding; Aterian said it did not believe any person or group acquired control.

Director Avraham Ben-Tzvi resigned effective September 25, 2026, and William H. Crampton joined the Board and its Audit and Compensation Committees. Crampton received a 301,205-share restricted stock award vesting over three years, subject to continued director service. The Compensation Committee approved a $150,000 retention bonus for Lazar tied to his continued leadership through the filing of Aterian’s Form 10-Q for the quarter ended September 30, 2026.

Aterian also announced an approximately $0.9936-per-CVR cash payment on or about October 2, 2026, subject to required tax withholding. The distribution relates to the July 17, 2026 asset sale to Trademark Global, LLC and Second SPA Closing, identified as Proceeds Events.

Rhea-AI Summary

Aterian, Inc. completed two connected transactions on July 17, 2026: sale of specified consumer-brand assets to Trademark Global, LLC for $18.0 million in cash, and issuance of convertible preferred stock to investor David E. Lazar for aggregate gross proceeds of $7.0 million.

The asset sale covers brands including Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions and Photo Paper Direct, while Aterian retains smaller brands such as Vremi and Xtava. The preferred financing comprised 1,750,000 Series AA and 1,750,000 Series AAA shares at $2.00 per share, each series convertible into common stock at fixed ratios.

Following the second preferred closing, Lazar beneficially owns about 95.8% of Aterian’s issued and outstanding voting securities, constituting a change in control; existing holders collectively own about 4.2% of voting power. Aterian repaid in full all indebtedness under its existing credit agreement and terminated related commitments, guarantees and liens.

The board declared a dividend of non-transferable contingent value rights linked to specified future cash proceeds, with an August 17, 2026 payment date for the dividend, though payments are not assured. Stockholders approved the asset sale, preferred-share conversion-related proposals, a reverse stock split range of 1-for-2 to 1-for-99, and an increase in authorized common shares up to 1,000,000,000.

Rhea-AI Summary

Aterian, Inc. convened a special stockholder meeting on July 10, 2026 and immediately adjourned it without conducting business. A quorum was present, with 5,278,277 shares, or 48.65% of common stock outstanding as of May 29, 2026, represented virtually or by proxy. The meeting was adjourned because there were not sufficient votes to approve the proposal to sell substantially all of Aterian’s assets to Trademark Global, LLC under an Asset Purchase Agreement dated April 27, 2026. The special meeting will reconvene on July 17, 2026 at 9:30 a.m. Eastern Time via live webcast, with the same record date and unchanged proposals, including the Asset Sale and a related investment transaction with David E. Lazar. Aterian highlights forward-looking statements about these transactions, potential dividends or contingent value rights, and notes risks such as its ability to continue as a going concern, maintain its Nasdaq listing, and meet financial covenants.

Rhea-AI Summary

Aterian, Inc. declared a special dividend of contingent value rights (CVRs) for common stockholders and certain warrant holders, tied to its previously announced asset sale to Trademark Global and preferred stock investment by David E. Lazar. Holders of common shares and eligible warrants as of the close on July 8, 2026 are currently expected to receive one CVR per share or warrant-share.

The Board may change the record date, set the payment date within 60 days of that date but no later than September 4, 2026, or revoke the dividend entirely based on updated solvency or surplus analysis. Aterian plans to route a portion of remaining cash and other proceeds from the asset sale, preferred investment and additional recoveries through the CVRs.

Based on current estimates, management expects between about $10.6 million and $14.2 million, or roughly $0.85 to $1.14 per share, could ultimately be available for distribution, after reserves and obligations. The company warns that these figures are uncertain, may be materially lower, and depend on post-closing adjustments, collections, reserves for specified liabilities and Board decisions.

Rhea-AI Summary

Aterian, Inc. agreed to sell the assets of its marquee e‑commerce brands, including Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions, and Photo Paper Direct, to Trademark Global for $18 million in cash, subject to working capital and other adjustments.

Separately, Aterian entered into a Securities Purchase Agreement with David E. Lazar for a $7.0 million private placement of Series AA and Series AAA convertible preferred stock at $2.00 per share. After the second closing and stockholder approvals, Lazar is expected to hold about 95.13% of Aterian’s fully diluted share capital, with existing holders at 4.87%.

The company plans a stockholder meeting to approve the Asset Sale, the preferred share conversions, an increase in authorized common shares to up to 1,000,000,000, and a reverse stock split between 1‑for‑2 and 1‑for‑99. Lazar has joined the Board and is expected to become sole Chief Executive Officer after the second closing, while Aterian continues smaller brands such as Vremi and Xtava and explores possible distributions and CVRs from sale proceeds.

Rhea-AI Summary

Aterian, Inc. provided an update on its ongoing review of strategic alternatives, which began in December 2025. The company reports that the process is progressing and that it is engaged in constructive discussions and evaluating various opportunities, with another update anticipated in mid-April.

The Board is formally exploring options to maximize shareholder value, including a potential sale of company assets, a sale of the company, a business combination, a merger or other strategic actions. Aterian has engaged A.G.P / Alliance Global Partners as financial advisor and Paul Hastings LLP as legal counsel, while emphasizing there is no assurance any specific transaction will occur or when the review will be completed.

Rhea-AI Summary

Aterian, Inc. entered into Amendment No. 5 to its existing Credit and Security Agreement. The original credit agreement, dated December 22, 2021, is between Aterian and certain subsidiaries as borrowers, lenders party from time to time, and Midcap Funding IV Trust as administrative agent.

The new amendment, dated March 13, 2026, modifies that prior credit arrangement, though specific changes are contained in the attached exhibit and not detailed in this text. The company filed the amendment as a material definitive agreement, signaling that the credit facility remains an important part of its financing structure.

Rhea-AI Summary

Aterian, Inc. filed an amended Form 8-K to update Item 5.07, reporting the company’s decision on how often it will hold future non-binding advisory votes on executive compensation (say-on-pay). This amendment follows the 2025 annual meeting results and fulfills Item 5.07(d) disclosure requirements. No other changes were made to the prior Form 8-K. An Inline XBRL cover page file is included as Exhibit 104.

Rhea-AI Summary

Aterian, Inc. furnished a current report to announce it issued a press release with financial results for the three and nine months ended September 30, 2025. The press release is attached as Exhibit 99.1.

The information was furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits) and is not deemed “filed” for purposes of Section 18 of the Exchange Act. The report was signed by Chief Executive Officer Arturo Rodriguez.

Rhea-AI Summary

Aterian, Inc. announced a leadership change. Chief Technology Officer Roi Zahut notified the company of his resignation, effective November 3, 2025. He will assist with the transition of his responsibilities through the effective date.

The company states Mr. Zahut is leaving to accept another executive position outside the company and that his resignation was not due to any disagreement regarding operations, policies, or practices.

Rhea-AI Summary

Aterian, Inc. announced Amendment No. 4 to its Credit and Security Agreement dated August 29, 2025, with Midcap Funding IV Trust as administrative agent. The amendment temporarily reduced the Minimum Credit Party Liquidity covenant to $5.0 million for the defined Minimum Liquidity Covenant Reduction Period.

The amendment provides that if the company delivers a Liquidity Certificate showing at least $6.8 million of liquidity, the reduction period will end and the covenant will reset to $6.8 million. The amendment also establishes an Availability Reserve of $2.8 million during the reduction period and $1.0 million thereafter. Non-material schedules and exhibits were omitted from the filing.

Rhea-AI Summary

Aterian, Inc. furnished a press release reporting its financial results for the three and six months ended June 30, 2025; that press release is attached as Exhibit 99.1 and is incorporated by reference into the Form 8-K. The Form 8-K notes that the information in Item 2.02, including Exhibit 99.1, is being furnished under the Exchange Act and expressly is not deemed to be filed for purposes of Section 18 and is not incorporated by reference into other filings except by specific reference. The filing also lists a Cover Page Interactive Data File as Exhibit 104. The 8-K provides notice that the company has publicly disclosed its quarterly results via the attached press release, but it does not include any financial line-item figures or performance metrics within the filing itself.